
What happened
Moonshot AI is redirecting its Kimi language models from coding toward biology, chemistry, and pharma research; Giacomo Ficari said at Web Summit in Lisbon that science demands smarter AI than law, finance, or code.
Why it matters
The pivot points Kimi at work that, by Moonshot's own framing, asks more of a model than coding does — a harder target than the coding benchmarks it is stepping away from.
WHO IT HITSThe move lands on research scientists and R&D teams in biology, chemistry, and pharma who would use AI assistants like BioMaster for tasks such as gene analysis. It may also affect enterprise software teams that had been evaluating Kimi for coding work, though the body does not say whether coding support continues.
Summaries like this, every morning.
The pivot comes as Moonshot AI sees diminishing returns in coding, where benchmark gains have flattened. Rather than keep chasing those scores, the company is repositioning Kimi toward domains it argues are harder for AI: biology, chemistry, and pharma research. That claim rests on the idea that scientific work demands smarter models than law, finance, or code — a framing Giacomo Ficari offered at Web Summit in Lisbon.
Early adoption is already taking shape. Beijing startup DP Technology is integrating Kimi K3.1 Pro into BioMaster, its research assistant, and a test on gene data from 3,696 mouse pancreatic cells suggests speed gains over manual human analysis. Yet the body is clear that fully independent breakthroughs remain distant: on the TCSExam benchmark, leading models produced verifiable proofs but could not solve any open conjectures alone. US rivals face similar limits — Anthropic's Claude found an enzyme system in September, while mathematicians criticized OpenAI's claimed math and physics breakthroughs.
The commercial audience is not fully convinced. A June Citi survey of 50 US research leaders found 72 percent already using AI broadly, but only 24 percent expect it to noticeably improve drug development success rates. That gap between adoption and expected impact is the backdrop against which Moonshot's science-first bet will be judged.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Nikkei xTECH published a beginner-oriented, step-by-step tutorial on implementing an approval-request function…

Avenue7Media rebranded as Ave7 and launched the Ave7 Marketplace Growth OS, combining expert operators with av…

Felix Rieseberg, who works on Claude at Anthropic, said on X that Claude can now build "bizarre & beautiful si…

Google's Threat Intelligence Group found an exposed server running "exploit_agent," an AI framework that conne…

Shareholders sued Intel, CEO Lip-Bu Tan and CFO David Zinsner, alleging statements about Intel's ability to ca…

Apple's iOS 27.3, iPadOS 27.3, and macOS 27.3 betas test daily usage limits for four categories of Siri AI and…
